Skip to main content

Ipilimumab and Nivolumab Combination Therapy: A Randomized Study of an Immediate versus Delayed Exercise Intervention with FuNctional Capacity and Quality of Life Evaluations in Subjects with Advanced

Clinical Trial Grant
Duke Scholars

Awarded By

Bristol-Myers Squibb Company

Start Date

July 30, 2018

End Date

June 30, 2020
 

Awarded By

Bristol-Myers Squibb Company

Start Date

July 30, 2018

End Date

June 30, 2020